Real-World Effectiveness and Tolerability of Sacubitril/Valsartan in Octogenarian Patients With Heart Failure: Results From the PARACHUTER Study

This publication has 9 references indexed in Scilit:

• Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF
  European Heart Journal, 2023
• Evidence-based Therapy in Older Patients with Heart Failure with Reduced Ejection Fraction
  Cardiac Failure Review, 2022
• Left Ventricular Diastolic Function in Healthy Adult Individuals: Results of the World Alliance Societies of Echocardiography Normal Values Study
  Journal of the American Society of Echocardiography, 2020
• Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
  New England Journal of Medicine, 2019
• Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF
  European Heart Journal, 2015
• Heart Failure as a General Pandemic in Asia
  European Journal of Heart Failure, 2015
• Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
  New England Journal of Medicine, 2014
• The Persistent Exclusion of Older Patients From Ongoing Clinical Trials Regarding Heart Failure
  Archives of internal medicine (1960), 2011
• The Natural History of Congestive Heart Failure: The Framingham Study
  New England Journal of Medicine, 1971